Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoGen Inc (NASDAQ:IMGN)

2.92
Delayed Data
As of 3:59pm ET
 +0.02 / +0.69%
Today’s Change
2.53
Today|||52-Week Range
16.59
-78.48%
Year-to-Date

Today’s Trading

Previous close2.90
Today’s open3.02
Day’s range2.84 - 3.02
Volume1,012,559
Average volume (3 months)1,989,033
Market cap$252.5M
Dividend yield--
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)-132.39%
Earnings growth (this year)+2.27%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-29.86%
P/E ratioNM
Price/Sales4.46
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RIGLRigel Pharmaceutical...-0.09-3.33%
EDGEEdge Therapeutics In...+0.06+0.67%
RXDXIgnyta Inc-0.10-1.70%
ESPREsperion Therapeutic...+0.13+1.24%
Data as of 3:59pm ET, 08/26/2016

Financials

Next reporting dateOctober 21, 2016
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$60.0M
Annual profit (last year)-$143.7M
Net profit margin-239.42%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Enyedy
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts

Partner Offers

Search for Jobs